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INTRODUCTION
Many people now recognize that naturally -occurring bioactive
compounds, called phytochemicals, could play important roles in
the maintenance of homeostasis and prevention of chronic human
diseases. Among the various phytochemicals, polyphenols are the
most popular family widely distributed in fruits, vegetables, bever-
ages, and cereals. They are defined according to the nature of their
backbone structures ; i.e., phenolic acids, flavonoids, stilbenes and
lignans. Flavonoids are the most abundant polyphenols in plant
foods, and are further divided into several classes ; i.e., flavones,
flavonols, isoflavones, flavanols, anthocyanins, proanthocyanidins,
flavanones, etc. Over eighty years ago, Rusznyák and Szent-
Györgyi discovered that citrus flavonoids attenuated capillary fra-
gility and permeability in blood vessels (1, 2). Flavonoids were first
believed to be a member of a new class of vitamins, and were
designated as vitamin P, but it has not been proven that flavonoids
meet the requirements to be called a vitamin. Quercetin (3,3’,4’,5,7 -
pentahydroxyflavone) is a major flavonoid in our daily diet, and
most of the quercetins in plants is in the glycoside form. The quer-
cetin glycosides are particularly abundant in onion (0.3 mg/g fresh
weight) (3), tea (10-25 mg/L) (4), and buckwheat (up to 3% dry
weight as rutin) (5). Epidemiological studies suggested the tight
links between the intake of flavonoid-rich diets and the decreased
incidence of various chronic age-related diseases (6-11). How-
ever, the bioavailability of flavonoids is generally low due to limited
absorption, extensive metabolism, and rapid excretion. Therefore,
the molecular mechanisms underlying the health-beneficial ac-
tions of flavonoids in vivo have not been fully clarified.
BIOAVAILABILITY OF DIETARY FLAVONOIDS
The bioavailability of quercetin and other polyphenols in humans,
as well as in rodents, has been well investigated. The flavonoid
glycosides, after oral intake, are rapidly hydrolyzed into the agly-
cones by lactase-phlorizin hydrolase or cytosolic β -glucosidase in
the small intestine or by bacterial glycosidases in the colon. The
aglycones are further metabolized through the phasereactions
into their glucuronides by UDP-glucuronosyltransferase and/or
sulfates by sulfotransferase, and if they have the catechol moiety,
some are also methylated by catechol -O -methyltransferase (COMT)
(12, 13). In the case of quercetin, it should be noted that non-con-
jugated aglycones, including methylquercetins, are scarcely de-
tected in the human plasma (14). For example, previous human
volunteer studies with onion intake have clearly shown that the
quercetin conjugates, such as quercetin-3 -O -glucuronide (Q3GA)
and quercetin-3’ -O -sulfate (Q3’S), are detected in human plasma,
while the aglycones could not be detected (14, 15). Quercetin
diglucuronide, sulfoglucuronide (diconjugate with sulfate and glu-
curonide), and isorhamnetin (3’ -methylquercetin) -3 -O -glucuro-
nide, as well as Q3GA and Q3’S, were also detected in human
plasma after the oral intake of onion (16). The total quercetin con-
centrations in human plasma after onion intake are up to several
μM at maximum (15, 16). It is generally recognized that phase-
reactions produce more polar, hydrophilic, biologically inactive
molecules that are more readily excreted into the urine. Indeed,
the phase-metabolism of flavonoids introduces hydrophilic
functionalities, such as glucuronic acid and sulfuric acid, onto the
relatively hydrophobic flavonoid structures and facilitates urinary
excretion. Therefore, there have been controversies about how the
inactive phase-metabolites of flavonoids exhibit the health-be-
neficial activity in vivo.
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DEVELOPMENT OF ANTIBODIES TO FLAVONOIDS
Thus, to resolve these controversies, we tried to identify the
localization and target sites of the flavonoid conjugates in vivo.We
speculated that there might be specific interactions of the flavonoid
conjugates with the target sites during blood circulation. However,
analytical methods for the localization of flavonoids in tissues and
cells have been limited to chromatographies (such as liquid chro-
matography combined with a UV/visible spectrophotometer,
electrochemical detector or mass spectrometer). To overcome the
difficulties, we developed specific antibodies to the flavonoid conju-
gates to immunohistochemically visualize their localizations in
vivo. We finally developed a monoclonal antibody, mAb14A2, by
immunizing mice with the Q3GA-keyhole limpet hemocyanin
complex. This antibody significantly recognized Q3GA, but nei-
ther the quercetin aglycone, the 3’ -methylated metabolite iso-
rhamnetin, nor a quercetin sulfate (17). This was the first report for
the development of antibodies to the in vivo metabolites of fla-
vonoids. Our laboratory has previously reported that orally adminis-
tered quercetin accumulated as conjugates in the aorta of hyper-
cholesterolemic rabbits with significant inhibition of the develop-
ment of atherosclerotic lesions (18), suggesting that quercetin conju-
gates could play important roles regarding the anti -atherosclerotic
effects in the aorta. We then immunohistochemically examined the
localization of Q3GA in human aortic tissues using this novel anti-
body and found that the immune-positive staining was specifically
detected in atherosclerotic lesions, mainly co- localized in the mac-
rophage-derived foam cells, but not in the normal aorta (18). In
contrast, the endothelial cells, smooth muscle cells, and extracellu-
lar matrix in the subendothelial layer, the so-called intima, were
scarcely stained with the anti -Q3GA antibody. On the other hand,
since we have previously revealed the presence of quercetin conju-
gates, associated with the anti -oxidative activity, in rat brain tissue
by liquid chromatography-mass spectrometry (19), we then im-
munohistochemically examined the localization of Q3GA in the
human brain and observed specific localization of Q3GA, espe-
cially in macrophages, at different stages of cerebral infarction
(20). These results suggested that Q3GA could accumulate in
macrophages, not only in the aorta, but also in the brain tissue.
Thus, immunohistochemical application of a novel monoclonal anti-
body strongly supported the presence of Q3GA in specific sites,
especially macrophages, in vivo.
In contrast to the observation that no quercetin aglycone was
detected in human plasma, tea catechins, such as (-) -epicatechin-3 -
gallate (ECg) and (-) -epigallocatechin-3 -gallate (EGCg), can be
detected in human plasma as the aglycones after the intake of
green tea (21). We have also developed a monoclonal antibody spe-
cific to the ECg aglycone and found the specific localization of the
immunoreactivity in macrophages in human atherosclerotic le-
sions (22). These results suggest that macrophages could be the
specific target not only of the conjugated metabolites, such as
Q3GA, but also perhaps of the aglycones including ECg. The sig-
nificant accumulation of Q3GA and ECg was also reproduced in
cultured macrophages in vitro, resulting in suppression of the
mRNA expression of scavenger receptors, scavenger receptor
class-A (SR-A) and CD36 (17, 22). These results suggest that the
interaction between flavonoids and macrophages might be crucial
for the anti -atherosclerotic actions of flavonoids in the aorta.
INTERACTION BETWEEN MACROPHAGE AND QU-
ERCETIN CONJUGATES
We further investigated in detail the interaction of Q3GA with
macrophages in vitro (Figure 1) and demonstrated that Q3GA is
bound to the cell surfaces on the macrophages (23). In contrast, the
quercetin aglycone could be incorporated into cells, rather than
bound to the cell surface, presumably via simple diffusion due to its
hydrophobicity. It was of interest that the quercetin and the methyl-
ated quercetins, not only Q3GA itself, were also significantly accu-
mulated in macrophages during incubation with Q3GA (17, 20, 23).
Intracellular accumulation of quercetin and methylquercetins in
the Q3GA-treated macrophages reflects the presence of the enzy-
matic activities of β -glucuronidase and COMT in the cells. These
non-conjugated aglycones were specifically detected in the macro-
phages after Q3GA-treatment,but not detected in the vascular en-
dothelial cells (human umbilical vein endothelial cells and bovine
aortic endothelial cells) and many other cell lines from different
tissues (23). Based on the general information that the COMT
activity is present inside the cells (24) and that Q3GA cannot be
incorporated into the cells, we concluded that the β -glucuronidase-
catalyzed deconjugation of Q3GA is the first step in the extracellular
fluid or cell surface and the formed quercetin aglycone can enter
the cells, followed by the COMT-catalyzed partial methylation of
the catechol moiety. To the best of our knowledge, the possible
demethylation of methylquercetins into quercetin has not yet been
revealed in vivo.
We demonstrated that the anti -atherosclerotic and/or anti - infla-
mmatory effects of Q3GA in activated macrophages are tightly
linked with the β -glucuronidase-mediated deconjugation (17, 20,
23). It is generally recognized that quercetin with a catechol
moiety is more bioactive (typically as an antioxidant) than the
methylquercetins. However, we observed that the COMT activity
enhanced the inhibitory effects of Q3GA on the SR-A expression in
macrophages (17), suggesting that partial methylation of quer-
cetin by COMT could provide alternative bioactive compounds, as
well as quercetin, inside the cells. Although the possibility as to
whether the glucuronides of other polyphenols could also be de-
conjugated into their aglycones remains unproven, these results
suggest that β -glucuronidase is a key enzyme for the “reactiva-
tion” of inactive flavonoid conjugates in vivo. The in vivo expres-
sion of β -glucuronidase is also immunohistochemically demon-
strated in the foamy macrophages in the atherosclerotic aorta of
the apolipoprotein E-deficient mice (25), showing the tight link
between the pro-atherogenic conditions and the deconjugation-
mediated anti -atherosclerotic of flavonoids in vivo. We also demon-
strated that the deconjugation of Q3GA was enhanced in the lipo-
polycassharide-stimulated macrophages (23). In addition, a sig-
nificant expression of β -glucuronidase in ICR mice was observed
in the thymus, liver and spleen, which may contain inflammatory
cells, such as lymphocytes, kupffer cells (in liver), and/or macro-
phages (23). Therefore, tissues with β -glucuronidase activity
could be the potential sites where the deconjugation of the fla-
vonoid glucuronides and the following actions of the aglycones
could occur in vivo.
It should be noted that, as far as we investigated, the sulfate
metabolites of quercetin could not be deconjugated during interac-
tion with the macrophages at least under our experimental condi-
tions (23). Galindo et al. reported that the intravenous injection of
Q3GA or isorhamnetin-3 -O -glucuronide, but not Q3’S, progres-
sively reduced the mean blood pressure in spontaneously hyper-
tensive rats, and furthermore, that the hypotensive effect of Q3GA
was abolished in rats treated with the β -glucuronidase inhibitor
(26). These observations suggest that the β -glucuronidase-med-
iated deconjugation of glucuronide metabolites, rather than the
sulfates, might represent a major pathway for exhibiting the bio-
logical activity in vivo after the quercetin intake. On the other hand,
the biological activity linked with sulfate metabolites has also been
suggested by the observations that the sulfate metabolites of res-
veratrol, a stilbene found in grape seed, induced autophagy and
senescence in human cancer cells and these effects were abro-
gated by a sulfatase inhibitor (27). However, the presence and
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localization of sulfatase for deconjugating sulfate metabolites have
not yet been fully characterized. In human plasma, Q3’S is more
abundant than Q3GA after the oral intake of quercetin (16). There-
fore, possible regulation of the sulfation/glucuronidation ratio of
the flavonoids by coexisting food components might optimize the
biological activity of the flavonoids in vivo. Application of natural
sulfotransferase inhibitors (28) to our daily diet will have the
possibility to enrich the glucuronidation of flavonoids resulting in
the enhanced biological activity throughthe β -glucuronidase-me-
diated deconjugation.
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